Tata India Pharma & Healthcare Fund Regular-Growth

Q: What are the returns of Tata India Pharma & HealthCare Fund?

The Tata India Pharma & HealthCare Fund is a 9 yrs 7 m old fund and has delivered average annual returns of 12.39% since inception. Tata India Pharma & HealthCare Fund Returns 1-Year 3-Year 5-Year Since Inception 12.83% 25.33% 22.39% 12.39%

NAV as of Jul 04, 2025	Returns since inception	ET Money Rank	AUM (Fund size)
₹30.6734+0.71% 1 day change	12.39% p.a.	#NA View Ranked Funds	₹1,232 Cr

Historical NAV & returns

NAV: ₹30.6734 as on Jul 04, 2025

This fund Category average

Tata India Pharma & HealthCare Fund overview

Expense ratio	2.12% as on May 31, 2025
Exit load	0.25% Exit load of 0.25% if redeemed within 30 days.!
AUM (Fund size)	₹1,232 Cr
Lock-in Period	Nil
Age	9 yrs 7 m since Dec 04, 2015
Benchmark	NIFTY Pharma TRI
Min. investment	SIP: ₹500 & Lumpsum: ₹5000
Risk	Very High
Short term capital gains (STCG)	Returns taxed at 20% if you redeem before 1 year
Long term capital gains (LTCG)	After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%

Tata India Pharma & HealthCare Fund Returns calculator

Investment type

Monthly investment

₹ 10,000

Investment period

Lumpsum investment

₹1 lakh

Investment period

Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully. Past performance is not an indicator of future returns.

Total investment ₹ 12 lakh
Profit ₹12 lakhs
Total corpus ₹1 lakh
Absolute return 52.69%

Trailing returns as on Jul 05, 2025

Period	This fund	Category average
1 Month	3.78%	3.65%
3 Months	12.64%	13.74%
6 Months	-2.55%	-1.23%
1 Year	12.83%	16.23%
2 Years	29.15%	29.6%
3 Years	25.33%	26.03%
4 Years	14.89%	14.6%
5 Years	22.39%	22.33%
7 Years	19.88%	20.67%

Asset allocationas on May 31, 2025

Large Cap 29.13%

Mid Cap 32.33%

Small Cap 29.37%

Other Cap 0%

Top holdings

Sun Pharmaceutical Industries Ltd.11.64%

Apollo Hospitals Enterprise Ltd.6.22%

Cipla Ltd.5.83%

Aurobindo Pharma Ltd.5.73%

Top sectors

Healthcare 87.22999999999999%

Services 2.19%

Chemicals 1.4100000000000001%

Credit quality

Bifurcation by Credit Quality is not available for this fund

Top Debt Holdings

Bifurcation by Holding is not available for this fund

Allocation by Instruments

Bifurcation by Instrument is not available for this fund

Other Holdings

Others 8.92%

Peer comparison

Fund name	ETM Rank	AUM	Fund age	Expense ratio
Tata India Pharma & HealthCare Fund	N.A.	1,232 Cr	9 yrs 7 m	2.12%
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund	N.A.	5,295 Cr	7 yrs	1.06%
SBI Healthcare Opportunities Fund	N.A.	3,671 Cr	12 yrs 6 m	0.9%
DSP Healthcare Fund	N.A.	2,961 Cr	6 yrs 8 m	0.62%
Tata India Pharma & HealthCare Fund	N.A.	1,232 Cr	9 yrs 7 m	0.63%
Mirae Asset Healthcare Fund	N.A.	2,691 Cr	7 yrs 1 m	0.5%

Fund name	1M	6M	1Y	3Y	5Y	10Y
Tata India Pharma & HealthCare Fund	3.78%	-2.55%	12.83%	25.33%	22.39%	N.A.
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund	3.43%	1.2%	20.63%	31.26%	26.07%	15.86%
SBI Healthcare Opportunities Fund	4.0%	0.59%	20.95%	31.0%	26.13%	13.11%
DSP Healthcare Fund	4.0%	-4.21%	15.5%	28.25%	25.24%	15.82%
Tata India Pharma & HealthCare Fund	3.9%	-1.8%	14.52%	27.21%	24.23%	13.52%
Mirae Asset Healthcare Fund	4.41%	-0.53%	17.02%	26.08%	24.35%	15.79%

Fund name	Std. deviation	Beta	Sharpe	Sortino
Tata India Pharma & HealthCare Fund	15.93	0.98	1.1	1.69
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund	15.37	0.94	1.44	2.04
SBI Healthcare Opportunities Fund	13.71	0.84	1.58	2.27
DSP Healthcare Fund	14.68	0.85	1.35	2.22
Tata India Pharma & HealthCare Fund	15.95	0.99	1.2	1.83
Mirae Asset Healthcare Fund	16.24	1.0	1.11	1.76

View all Sectoral-pharma funds

Key risk & return ratios Compared to other funds in the category

Alpha	-1.86 vs. 6.7 Underperformed at beating benchmark
Sharpe	1.1 vs. 4.61 Poor risk-adjusted returns
Beta	0.98 vs. 0.79 More sensitive to market's ups & downs
Standard deviation	15.93 vs. 9.0 More volatile performance

Compare Tata India Pharma & HealthCare Fund in detail with

About this fund

About Tata India Pharma & HealthCare Fund

Tata India Pharma & Healthcare Fund Regular-Growth is a Sectoral-Pharma mutual fund scheme from Tata Mutual Fund. This fund has been in existence for 9 yrs 7 m, having been launched on 04/12/2015. Tata India Pharma & Healthcare Fund Regular-Growth has ₹1,232 Crores worth of assets under management (AUM) as on 31/05/2025 and is medium-sized fund of its category. The latest Net Asset Value (NAV) of Tata India Pharma & Healthcare Fund Regular-Growth as of 04/07/2025 is ₹30.67. The fund has an expense ratio of 2.12%, which is higher than what most other Sectoral-pharma funds charge.

Tata India Pharma & Healthcare Fund Regular-Growth returns of last 1-year are 14.06%. Since launch, it has delivered 12.49% average annual returns. The fund has doubled the money invested in it every 4 yrs.
Tata India Pharma & Healthcare Fund Regular-Growth scheme's ability to deliver returns consistently is in-line with most funds of its category. Its ability to control losses in a falling market is average.
The fund has the majority of its money invested in Healthcare, Services, Chemicals sectors. It has taken less exposure in Healthcare, Services sectors compared to other funds in the category.
The fund's top 5 holdings are in Sun Pharmaceutical Industries Ltd., Apollo Hospitals Enterprise Ltd., Cipla Ltd., Aurobindo Pharma Ltd., Divi's Laboratories Ltd..

...

Fund AUM	1,232 Cr as on May 31, 2025
Scheme document	View Scheme Document

Fund managers

Meeta Shetty

Ms. Shetty is Bachelor in Economics and CFA Charterholder Prior to joining TATA Mutual Fund, she has worked with Kotak Securities, HDFC Securities, AMSEC(Asian Market Securities), Dalal & Broacha Stock Broking and karvey Stock Broking.

Rajat Srivastava

Mr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services

Investment objective

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Tata Mutual Fund details

No. of schemes	57 view all schemes
Total AUM	1,88,061 Cr as on Mar 31, 2025
Address	9th Floor, Mafatlal Centre, Nariman Point, Mumbai, 400021
Email	service@tataamc.com
Phone	1800-209-0101

More funds from Tata Mutual Fund

Fund name	ETM Rank	AUM	1Y	5Y
Tata Small Cap Fund	N.A.	10,529 Cr	2.97%	35.77%
Tata Infrastructure Fund	N.A.	2,227 Cr	-12.74%	31.51%
Tata Digital India Fund	N.A.	11,688 Cr	6.29%	29.07%
Tata Mid Cap Fund	N.A.	4,701 Cr	-0.14%	28.53%
Tata Resources & Energy Fund	N.A.	1,118 Cr	4.69%	26.94%
Tata India Pharma & HealthCare Fund	N.A.	1,232 Cr	14.52%	24.23%

See all Equity funds from this AMC

Frequently asked questions

What is the current NAV of Tata India Pharma & HealthCare Fund?

The current Net Asset Value (NAV) of the Tata India Pharma & HealthCare Fund - Direct Growth plan is approximately ₹30.6734 as of Jul 04, 2025.

What are the returns of this mutual fund scheme?

The Tata India Pharma & HealthCare Fund is a 9 yrs 7 m old fund and has delivered average annual returns of 12.39% since inception.

Tata India Pharma & HealthCare Fund Returns

1-Year	3-Year	5-Year	Since Inception
12.83%	25.33%	22.39%	12.39%

How much does this mutual fund charge as expense ratio?

The Tata India Pharma & HealthCare Fund - Direct Growth has an expense ratio of 2.12%, which reflects the fund's management and operating costs. This percentage is subtracted from the fund's annual returns, impacting net returns for investors.

What is the AUM or fund size of this mutual fund?

The Tata India Pharma & HealthCare Fund currently has assets under management (AUM) or fund size valued at approximately 1,232 Cr as on May 31, 2025.

What are the top stock holdings of Tata India Pharma & HealthCare Fund?

The Tata India Pharma & HealthCare Fund has invested the majority of its money in the stocks of the following companies -

Company	Percentage of Portfolio
Sun Pharmaceutical Industries Ltd.	11.64%
Apollo Hospitals Enterprise Ltd.	6.22%
Cipla Ltd.	5.83%
Aurobindo Pharma Ltd.	5.73%
Divi's Laboratories Ltd.	5.63%
Fortis Healthcare Ltd.	4.9%
Lupin Ltd.	4.82%
Aster DM Healthcare Ltd.	4.35%
Wockhardt Ltd.	3.27%
Dr. Reddy's Laboratories Ltd.	3.16%

What are the top sectors Tata India Pharma & HealthCare Fund has invested in?

The Tata India Pharma & HealthCare Fund has primarily invested in the following sectors

Sector	Percentage of Portfolio
Healthcare	87.22999999999999%
Services	2.19%
Chemicals	1.4100000000000001%

What is risk level of Tata India Pharma & HealthCare Fund?

This is a Sectoral-pharma fund comes with Very High risk.

Is there any lock-in period in this mutual fund?

No, this fund does not have any lock-in period.

How do I invest in Tata India Pharma & HealthCare Fund?

Tata India Pharma & Healthcare Fund Regular-Growth is the regular plan of the fund. For this plan of you pay 2.12% as annual charges. On the other hand if you go for the direct plan available on ET Money, you pay 0.63%. That's 1.4900000000000002% less.

Regular plans charge more because when you buy them, the fund pays commission to the agent. This is an additional expense for the fund and to cover this expense, the fund takes a bigger share from the returns generated by your investments.

So, the lower annual cost of the direct plan means you will earn 1.4900000000000002% if you opt for direct plan of Tata India Pharma & HealthCare Fund

How can I redeem my investments in Tata India Pharma & HealthCare Fund?

Redeeming your investments in Tata India Pharma & HealthCare Fund is super easy. If you have invested in this fund via ET Money, just login into the app, go to the investment section and put the redemption request.

If you have invested in Tata India Pharma & HealthCare Fund from anywhere else, you can go to the fund house website and put a request through it.

ET Money rank

in Sectoral-Pharma

#NA

Volatility Protection: This fund is one of the best in protecting against volatility in it's category.
Return Outperformance: This fund has generated highest return amongst Sectoral-Pharma funds in the last 1 Month.
Return/Risk: The fund is performing poorly than its category.
Exit Load: Exit load of 0.25% if redeemed within 30 days.